A missense variant in the SID1transmembrane family member 2 (SIDT2) gene (Val636Ile, rs17120425) associates with raised HDL-C levels and reduced CHD risk, apparently by improving HDL function [46]. Here, SIDT2 is linked to coronary artery disorder.